Bone Biologics Corp

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Bone Biologics Corp
Former names: AFH Acquisition X, INC.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies
Jurisdiction of incorporation: Delaware
Headquarters city: Burlington
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: BBLG
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001419554
EIN: 42-1743430

Board of directors

Follow this board

Bruce Stroever · Director
Since 2023
Don Hankey · Director · Chairman of the Board
Since 2023
Erick Lucera · Director
Since 2023
Phillip Terry Meikle II · Director
Since 2024
Robert E. Gagnon · Director
Since 2024
Siddhesh Rajendra Angle · Director
Since 2023

Director election results

Annual meeting of May 30, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 5 other boards. 4 are in the same sector.

Shared director Other board Same sector

Beyond Air Inc. Same sector
via Erick Lucera
Harvard Bioscience Inc.
via Robert E. Gagnon
Purple Biotech Ltd. Same sector
via Robert E. Gagnon
SAB Biotherapeutics Inc. Same sector
via Erick Lucera
Verastem Inc. Same sector
via Robert E. Gagnon

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 13, 2023	Walsh Deina H Officer (Chief Financial Officer)	Open-market purchase	+8,000	$0.64	$5,120
Sep 11, 2023	Frelick Jeff Officer (Chief Executive Officer)	Open-market purchase	+9,500	$0.69	$6,555
Sep 6, 2023	Walsh Deina H Officer (Chief Financial Officer)	Open-market purchase	+300	$0.70	$210
Sep 6, 2023	Walsh Deina H Officer (Chief Financial Officer)	Open-market purchase	+6,700	$0.71	$4,757
Aug 31, 2023	Frelick Jeff Officer (Chief Executive Officer)	Open-market purchase	+7,600	$0.66	$5,016
Mar 13, 2023	Don Hankey Director, Officer (Chairman of the Board), 10% owner	Other	−500,137	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Bone Biologics Corp

How many directors are on Bone Biologics Corp's board?

Bone Biologics Corp's board has 6 directors: Bruce Stroever, Don Hankey, Erick Lucera, Phillip Terry Meikle II, Robert E. Gagnon and Siddhesh Rajendra Angle.

How is Bone Biologics Corp connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="bone-biologics-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.